We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.50 | -2.70% | 90.00 | 85.00 | 95.00 | 92.50 | 90.00 | 92.50 | 3,610 | 08:21:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.11 | 12M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/8/2022 17:25 | We’ve heard this before, clinicians want it but appears nobody wants to pay for it! | ducatiman | |
12/8/2022 12:09 | Small survey of Indian doctors by Feedback. | lr2 | |
11/8/2022 13:29 | Best get a move on as the ABS pump gone in my car and also need a new clutch ffs. | digger2779 | |
11/8/2022 09:05 | Technology hub. Home to India's largest medical tourism industry. Wealthy city. A good base for a medical start up isn't it? | lr2 | |
11/8/2022 08:52 | Interesting! Gurgaon is in the North. Odisha in the South. Tweet just sent from there or is Bleepa in the North as well? | ged5 | |
11/8/2022 07:49 | Things going well in India? | lr2 | |
06/8/2022 14:25 | Cyber attack on NHS 😏. Another reason to use Carelocker? | ducatiman | |
05/8/2022 14:21 | He's been busy twittering | digger2779 | |
05/8/2022 13:35 | 'Feedback has evolved its proposition to focus on flagship product Bleepa, which targets a broader clinical audience and cross provider opportunities with increasingly visible revenue streams. Company to focus more resources at the growing opportunity for Bleepa, both domestically and internationally ' Above comments in the RNS just three weeks ago so perhaps a bit harsh above. But is this the reality or are they just words? 'Redirecting internal resource away from legacy products towards high margin growth opportunities is essential to delivering greater value for shareholders and underpins the Company's strategy to move into larger addressable market opportunities.' Again fine words but I've been here some time now and not seen much value. Getting a contract seems as hard as signing de Jong! You've had your nappy duty break now just get on with it. | ged5 | |
05/8/2022 12:19 | So no updates on our veterinary incursion, Indian market and precious little on our NHS work. Well it is holiday time ffs. | digger2779 | |
05/8/2022 09:14 | Yet another night woken up by the sound of torrential rain. Drought! What drought? May be down south but not in the North West. Maybe Tom should re-locate to bring an end to this drought of news. | ged5 | |
03/8/2022 16:00 | Bleepa was introduced into the Indian market 4 months ago. I wonder if we will get a progress update any day soon. | lr2 | |
27/7/2022 16:18 | And reply now sent. Hope it helps. | lr2 | |
27/7/2022 14:24 | Thanks, email sent. | milfeddyg | |
27/7/2022 13:18 | Hello stranger, yes I am. The one on hotmail. | lr2 | |
27/7/2022 13:15 | Hi LR2, Are you still using the same email address? | milfeddyg | |
26/7/2022 18:08 | A couple of 5 million trades after hours. | lr2 | |
26/7/2022 12:38 | As we invest in digital infrastructure to support our healthcare systems it is more important than ever to ensure it is prepared for extreme weather conditions, following reports of outages caused by the recent heatwave. #nhs #digitalhealthcare #fdbk | lr2 | |
26/7/2022 12:33 | Half way there. | lr2 | |
26/7/2022 11:43 | Can't wait until we become a "true" penny share instead of a fraction thereof. | digger2779 | |
25/7/2022 17:02 | 7 million sell weighing the price down. Well done Thomas boy, great job! | petekand | |
25/7/2022 16:58 | and China lack of manufacturing too.... | intoodeep |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions